equitymaster.comFalseFalseVANTA BIOSCIENCE |
|
Price History |
Price | Rs | 64.0 | | % ch | % | -5.0 |
Mkt Cap | Rs m | 404 | | No. of
shares | m | 6.31 |
Vol | '000 | 4.5 | | % ch week | % | 0.0 |
P/E | X | | | % ch 1-mth | % | 0.0 |
P/CF | X | -5.2 | | % ch 12-mth | % | - |
EPS (TTM) | Rs | 0.0 | | 52 week H/L | Rs | 101.6/37.0 |
(As on Mar 28, 2024 (Close)) |
|
Financials |
* Results Consolidated | No. of Months
Year Ending | 12
Mar-19* | 12
Mar-20* | 12
Mar-21* | 12
Mar-22* | 12
Mar-23* |
EQUITY SHARE DATA |
High | Rs | 153 | 195 | 196 | 190 | 138 |
Low | Rs | 46 | 80 | 80 | 105 | 56 |
Sales per share (Unadj.) | Rs | 18.6 | 21.2 | 15.2 | 15.4 | 9.9 |
Earnings per share (Unadj.) | Rs | 1.1 | 1.6 | 0.7 | 0.2 | -16.6 |
Diluted earnings per share | Rs | 1.1 | 1.6 | 0.7 | 0.2 | -16.5 |
Cash flow per share (Unadj.) | Rs | 2.2 | 3.5 | 2.7 | 2.3 | -12.3 |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 |
Book value per share (Unadj.) | Rs | 35.3 | 37.2 | 37.9 | 38.0 | 27.8 |
Adj. book value per share | Rs | 35.2 | 37.2 | 37.9 | 38.0 | 27.7 |
Shares outstanding (eoy) | m | 6.31 | 6.31 | 6.31 | 6.31 | 6.31 |
Bonus / Rights / Conversions | | 0 | 0 | 0 | 0 | 0 |
Price / Sales ratio | x | 5.4 | 6.5 | 9.1 | 9.6 | 9.7 |
Avg P/E ratio | x | 90.0 | 85.7 | 194.0 | 690.9 | -5.8 |
P/CF ratio (eoy) | x | 44.6 | 39.4 | 51.2 | 64.2 | -7.8 |
Price / Book Value ratio | x | 2.8 | 3.7 | 3.6 | 3.9 | 3.5 |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 |
Avg Mkt Cap | Rs m | 628 | 868 | 869 | 931 | 610 |
No. of employees | `000 | NA | NA | NA | NA | NA |
Total wages/salary | Rs m | 29 | 39 | 25 | 27 | 35 |
Avg. sales/employee | Rs Th | 0 | 0 | 0 | 0 | 0 |
Avg. wages/employee | Rs Th | 0 | 0 | 0 | 0 | 0 |
Avg. net profit/employee | Rs Th | 0 | 0 | 0 | 0 | 0 |
INCOME DATA |
Net Sales | Rs m | 117 | 134 | 96 | 97 | 63 |
Other income | Rs m | 2 | 1 | 0 | 4 | 7 |
Total revenues | Rs m | 120 | 135 | 96 | 101 | 70 |
Gross profit | Rs m | 33 | 44 | 39 | 35 | -24 |
Depreciation | Rs m | 7 | 12 | 13 | 13 | 27 |
Interest | Rs m | 17 | 19 | 21 | 23 | 59 |
Profit before tax | Rs m | 11 | 13 | 6 | 2 | -103 |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 |
Tax | Rs m | 4 | 3 | 1 | 1 | 2 |
Profit after tax | Rs m | 7 | 10 | 4 | 1 | -104 |
Gross profit margin | % | 27.9 | 32.7 | 41.1 | 35.8 | -38.1 |
Effective tax rate | % | 36.7 | 24.5 | 23.9 | 41.1 | -1.8 |
Net profit margin | % | 5.9 | 7.6 | 4.7 | 1.4 | -166.4 |
BALANCE SHEET DATA |
Current assets | Rs m | 172 | 200 | 200 | 145 | 152 |
Current liabilities | Rs m | 33 | 100 | 149 | 143 | 177 |
Net working cap to sales | % | 118.0 | 74.6 | 53.1 | 2.3 | -39.9 |
Current ratio | x | 5.2 | 2.0 | 1.3 | 1.0 | 0.9 |
Inventory Days | Days | 72 | 26 | 37 | 87 | 95 |
Debtors Days | Days | 48,641,630 | 38,000,990 | 76,662,179 | 42,727 | 113,923 |
Net fixed assets | Rs m | 219 | 287 | 497 | 669 | 695 |
Share capital | Rs m | 63 | 63 | 63 | 63 | 63 |
"Free" reserves | Rs m | 159 | 172 | 176 | 177 | 112 |
Net worth | Rs m | 222 | 235 | 239 | 240 | 175 |
Long term debt | Rs m | 122 | 137 | 278 | 370 | 471 |
Total assets | Rs m | 391 | 487 | 697 | 814 | 847 |
Interest coverage | x | 1.7 | 1.7 | 1.3 | 1.1 | -0.7 |
Debt to equity ratio | x | 0.5 | 0.6 | 1.2 | 1.5 | 2.7 |
Sales to assets ratio | x | 0.3 | 0.3 | 0.1 | 0.1 | 0.1 |
Return on assets | % | 6.1 | 6.1 | 3.7 | 3.0 | -5.4 |
Return on equity | % | 3.1 | 4.3 | 1.9 | 0.6 | -59.6 |
Return on capital | % | 8.1 | 8.9 | 5.3 | 4.2 | -6.8 |
Exports to sales | % | 32.0 | 51.4 | 70.1 | 0 | 34.3 |
Imports to sales | % | 10.8 | 0.8 | 2.1 | 0 | 0 |
Exports (fob) | Rs m | 38 | 69 | 67 | 0 | 22 |
Imports (cif) | Rs m | 13 | 1 | 2 | 0 | 0 |
Fx inflow | Rs m | 38 | 69 | 67 | 0 | 22 |
Fx outflow | Rs m | 14 | 3 | 3 | 0 | 0 |
Net fx | Rs m | 24 | 65 | 65 | 0 | 22 |
CASH FLOW |
From Operations | Rs m | -10 | 23 | 70 | 53 | -6 |
From Investments | Rs m | -55 | -74 | -222 | -172 | -59 |
From Financial Activity | Rs m | 97 | 19 | 177 | 95 | 64 |
Net Cashflow | Rs m | 32 | -31 | 25 | -24 | -1 |
* Results Consolidated | Source: Company Annual Reports, Regulatory Filings, Equitymaster |
|
Share Holding |
Indian Promoters: | 69.4% |
Foreign collaborators: | 0.0% |
Indian inst/Mut Fund: | 0.0% |
FIIs: | 0.0% |
ADR/GDR: | 0.0% |
Free float: | 30.6% |
Shareholders: | 388 |
Pledged promoter(s) holding: | 0.0% |
|
Company Information |
REGD OFF: | No.02/ G/308/ G No.3/ F F/ S F/1-20-248, Umajay Complex, Rasoolpura Secunderabad, Hyderabad - 500003 |
E-MAIL: | cs@vantabio.com / info@vantabio.com |
WEB: | www.vantabio.com |
TELEPHONE: | 040-6657 5454 / 2790 3226 |
FAX: | 040-2790 8708 |
SECTOR: | BUSINESS SUPPORT |
GROUP: | Private sector |
TR AGENT: | Bigshare Services Pvt Ltd, 306 Right Wing Amrutha Ville Opp. Yasodha Hospital, Raj Bhavan Road, Somajiguda |
CHM: | Mohan Krishna Mulakala |
COMP SEC: | Vidisha Rathod |
YEAR OF INC: | 2016 |
BSE CODE: | 540729 |
FV (Rs): | 10 |
DIV YIELD (%): | - |